Pet parents & vets always feared Parvo virus in puppies. This devastating disease used to have no proven therapy, a guarded prognosis, & required extensive hospitalization without a guarantee for a successful outcome. Parvo was always associated with fear, anxiety, & stress for everyone involved in Parvo virus care.

Canine parvovirus monoclonal antibody is the answer to our long awaited prayers.

Canine parvovirus (Parvo) is one of the most common causes of illness & death in dogs worldwide.

While vaccination helps prevent parvo, there were no antiviral treatment options for dogs who become infected, until now.

Canine Parvovirus Monoclonal Antibody (CPMA) is the first & only USDA-conditionally approved, one-dose parvovirus treatment.

With just one intravenous dose, CPMA may shorten the course of the disease & improve the outcome.

A study of infected dogs who were treated with CPMA showed significantly faster resolution of symptoms including vomiting, lethargy & lack of appetite.Well tolerated in puppies as young as 6 weeks of age. In a safety study of 147 healthy dogs who received CPMA, CPMA was well tolerated. If a reaction occurred, it was generally mild & recovered within one day.

Use of CPMA helps decrease hospitalization time for parvovirus treatment.

Canine parvovirus is a highly contagious disease that destroys the intestinal lining. It can be fatal if not treated quickly.

Puppies are at high risk for parvo until they have been fully vaccinated, & unvaccinated dogs are also at risk.

If you notice any of the following signs, call your veterinarian immediately & ask about canine parvovirus & CPMA as a potential treatment.

1. Lack of appetite
2. Vomiting
3. Hemorrhagic (bloody) diarrhea
4. Abdominal pain
5. Lethargy
6. Fever

Call your veterinarian right away if you think your dog may have parvovirus & ask about CPMA by Elanco.